Jacobp Thyssen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Almirall, S.A. (ALM), a global biopharmaceutical company focused on medical dermatology, announced today the publication of Week 16 and Week 52 results of ADvocate1 and ADvocate2 by the New England Journal of Medicine (NEJM) and the British Journal of Dermatology (BJD), respectively. ADvocate1 and ADvocate2 are two ...

WEDNESDAY, March 2, 2022 (HealthDay News) — The overall risk for acne is comparable for adults with atopic dermatitis (AD) and controls, according to a study published online Feb. 26 in the Journal of the European Academy of Dermatology and Venereology. Jacob P. Thyssen, M.D., Ph.D., from the University of Copenhagen in Denmark, and colleagues […]

WEDNESDAY, March 2, 2022 (HealthDay News) -- The overall risk for acne is comparable for adults with atopic dermatitis (AD) and controls, according to a study published online Feb. 26

WEDNESDAY, March 2, 2022 (HealthDay News) -- The overall risk for acne is comparable for adults with atopic dermatitis (AD) and controls, according to a study published online Feb. 26

'This is an area that will continue to evolve, and further understanding will improve the healthcare advice that we provide to our patients,' Dr Jacob P. Thyssen said.